Buy-out Art,
1) Endo has first right of refusal on pelvic....nothing else.
2) The Bains of the world are either still licking their Lehman wounds or focusing on substantially bigger fish than a Belleville pharma-hobby. We are nowhere near the radar of Gecko-ish outfits...so a hack and slash fire-sale will never happen.
3) BNC has a business plan and they are executing it. My prime issue with them is with the veil of secrecy they envoke....that and the fact that they obviously concern themselves with padding their and the Friends of BNC (tm) pockets more than the retail shareholder....hopefully Mr. Rae can bring some acumen to the team but he may well be a McRae friend like the others.....
In the end, even a business lightweight like McRae can't stop what BNC has....he may well sell for pennies on the dollar but the value in BNC is there for all to see.....
McRae might be a lightweight but Endo are super-middleweights and they know that if they cough up more pennies on further MCC trials, it just shoots their take-out negotiations in the foot....riddle me this, do you think the price for MCC/Human or BNC in total goes up or down if Endo lights up more trials thereby confirming the value of the molecule??? I fully expect that BNC wants to start new trials up badly, but can't afford it, Endo wants to start new trials badly but doesn't want to show their hand until absolutely necessary....and the rest watch and circle by the sidelines waiting for the right time to engage....